Well, actually at ZymoGenetics.
Bristol-Myers Squibb (BMS), which acquired ZymoGenetics for $885 million in 2010, disclosed its plans for the 63 employees in a mass layoff warning filed with the Washington state Department of Employment Security on Thursday.
https://www.bizjournals.com/seattle/news/2018/11/01/bristol-myers-squibb-zymogenetics-layoffs.html